,47–50 Triple negative breast cancer (TNBC) was predominantly observed in BRCA1 mutation carriers, while BRCA2 mutation carriers more commonly presented with the luminal phenotype breast cancer or DCIS. Here, BRCA1 is linked to breast carcinoma.